Europris ASA (FRA:2RG)

Intra-Cellular Therapies Revenue

Europris ASA had revenue of 3.80B NOK in the quarter ending June 30, 2025, with 22.28% growth. This brings the company's revenue in the last twelve months to 14.36B, up 38.58% year-over-year. In the year 2024, Europris ASA had annual revenue of 12.75B with 34.68% growth.

• Revenue (ttm): 14.36B NOK
• Revenue Growth: +38.58%
• P/S Ratio: 1.10
• Revenue / Employee: 1.80M NOK
• Employees: 7,977
• Market Cap: 1.33B USD

Revenue Chart

* This company reports financials in NOK.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	12.75B	3.28B	34.68%
Dec 31, 2023	9.47B	451.15M	5.00%
Dec 31, 2022	9.02B	367.59M	4.25%
Dec 31, 2021	8.65B	635.55M	7.93%
Dec 31, 2020	8.01B	1.78B	28.52%